Fund Tracker India by Ishaan Dungarwal
Guide

Kotak Healthcare Fund

Holdings for Oct 2026, changes against Sep 2026, from Kotak Mahindra Mutual Fund's monthly file.

Kotak Healthcare Fund portfolio holdings, Oct 2026: 34 stocks, ₹852 cr in listed equity, from Kotak Mahindra Mutual Fund's monthly disclosure; changes by share count against Sep 2026.

Fund managers: Dhananjay Tikariha; Abhishek Bisen

Benchmark: Nifty Healthcare Index (Total Return Index) · Riskometer: Very High · SEBI category, as filed: Sectoral Fund · Allotted 12 Dec 2023

Source: AMFI scheme summary document

NAV

Kotak Healthcare Fund - Direct Plan - Growth Option

Source: AMFI

₹18.735020 Nov 2026
AUM

average for July - September 2026, all plans.

Source: AMFI

₹743 crJuly - September 2026
Expense ratio

The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.

Category median: direct 1.23 %, regular 2.40 % (174 schemes) · Regular costs ₹1,493 more a year per ₹1 lakh

Of this, the base expense ratio, the part SEBI caps: direct 0.69 %, regular 1.94 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.

A year, as of 17 Nov 2026. Source: AMFI · Glossary: TER

Direct 0.99 %Regular 2.48 %
Equity held

34 stocks, Oct 2026.

Source: Kotak Mahindra Mutual Fund monthly portfolio

₹852 cr34 stocks · Oct 2026
Equity, % of fund

As the AMC's file prints % of NAV. The top 10 stocks together: 54.9%.

99.0%top 10 stocks 54.9%

This month: Oct 2026

compared with Sep 2026 · by share count

Equity held vs NAV

The teal line is the scheme's equity at month end, from its portfolio file; the faint line is the plan's NAV. Equity held moves with prices and with money in or out, the NAV with prices only.

last 12 months to Oct 2026
Nov 2025: equity held ₹477 cr, 30 stocks, NAV ₹14.12Dec 2025: equity held ₹451 cr, 31 stocks, NAV ₹13.71Jan 2026: equity held ₹443 cr, 32 stocks, NAV ₹13.19Feb 2026: equity held ₹479 cr, 32 stocks, NAV ₹14.24Mar 2026: equity held ₹440 cr, 32 stocks, NAV ₹13.65Apr 2026: equity held ₹491 cr, 33 stocks, NAV ₹14.64May 2026: equity held ₹554 cr, 34 stocks, NAV ₹15.59Jun 2026: equity held ₹671 cr, 34 stocks, NAV ₹16.65Jul 2026: equity held ₹674 cr, 32 stocks, NAV ₹17.24Aug 2026: equity held ₹765 cr, 35 stocks, NAV ₹17.86Sep 2026: equity held ₹814 cr, 35 stocks, NAV ₹17.55Oct 2026: equity held ₹852 cr, 34 stocks, NAV ₹17.44
% change and month by month (tables)
% change to Oct 2026
OverSinceEquity heldNAV
3 monthsJul 2026▲ +26.4%▲ +1.2%
6 monthsApr 2026▲ +73.4%▲ +19.1%
12 monthsOct 2025▲ +79.4%▲ +24.1%
MonthEquity heldStocksNAV at month end
Nov 2025₹477 cr30₹14.1200
Dec 2025₹451 cr31₹13.7050
Jan 2026₹443 cr32₹13.1860
Feb 2026₹479 cr32₹14.2440
Mar 2026₹440 cr32₹13.6550
Apr 2026₹491 cr33₹14.6430
May 2026₹554 cr34₹15.5850
Jun 2026₹671 cr34₹16.6480
Jul 2026₹674 cr32₹17.2360
Aug 2026₹765 cr35₹17.8620
Sep 2026₹814 cr35₹17.5530
Oct 2026₹852 cr34₹17.4440
Oct 2026 · Sources: AMC monthly portfolio (SEBI disclosure); AMFI NAV files · How to read

Moves, Oct 2026

How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.

vs Sep 2026
  • New1
  • Added9
  • Trimmed0
  • Exited2
Stocks, by share count · Source: Kotak Mahindra Mutual Fund monthly portfolios Report a wrong number

Asset mix, Oct 2026

How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.

% of fund
  1. Listed equity
    99.0%
  2. Rest, not itemised
    1.0%
Source: Kotak Mahindra Mutual Fund monthly portfolio

Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.

Sectors and top 10, Oct 2026

Sector mix, Oct 2026

How the scheme's equity is spread across sectors at month end.

% of equity held
Source: Kotak Mahindra Mutual Fund monthly portfolio; AMFI

AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.

Report a wrong number

Large, mid and small cap, Oct 2026

How the scheme's equity splits across large, mid and small companies, on AMFI's list.

% of equity held
  1. Large Cap
    34.7%
  2. Small Cap
    34.5%
  3. Mid Cap
    21.4%
  4. Not in AMFI's list
    9.3%
Source: Kotak Mahindra Mutual Fund monthly portfolio; AMFI

AMFI's list of Jun 2026.

Report a wrong number

Top 10 holdings

Its ten largest stocks, each as a share of the fund.

% of fund · 54.9% together
  1. 13.42%
  2. 10.23%
  3. 4.88%
  4. 4.74%
  5. 4.29%
  6. 4.19%
  7. 3.50%
  8. 3.24%
  9. 3.24%
  10. 3.20%
Source: Kotak Mahindra Mutual Fund monthly portfolio

As the AMC's file prints % of NAV.

Changes, Oct 2026 vs Sep 2026

Every stock whose share count changed: new, added, trimmed, exited.

12 stocks · by share count
StockChangeShares beforeShares nowDifferenceChange %Value of changeValue now
PARASHLTH New—2.30 lakh+2.30 lakh—+₹17.0 cr₹17.0 cr
SUNPHARMA Added6.00 lakh6.50 lakh+50,000+8.3%+₹8.9 cr₹116 cr
DIVISLAB Added83,00090,000+7,000+8.4%+₹6.8 cr₹88.0 cr
LAURUSLABS Added1.20 lakh1.50 lakh+30,000+25.0%+₹7.2 cr₹36.1 cr
MAXHEALTH Added3.20 lakh3.50 lakh+30,000+9.4%+₹2.6 cr₹30.1 cr
APOLLOHOSP Added30,00033,000+3,000+10.0%+₹2.5 cr₹27.9 cr
FORTIS Added2.50 lakh2.80 lakh+30,000+12.0%+₹2.3 cr₹21.5 cr
PRASOLCHEM Added2.20 lakh2.65 lakh+44,750+20.3%+₹3.6 cr₹21.3 cr
ZYDUSLIFE Added75,0001.25 lakh+50,000+66.7%+₹6.2 cr₹15.6 cr
METROPOLIS Added1.50 lakh2.00 lakh+50,000+33.3%+₹2.7 cr₹10.9 cr
RAINBOW Exited70,000—−70,000—−₹9.2 cr₹9.2 cr
PFIZER Exited19,000—−19,000—−₹7.4 cr₹7.4 cr
Source: Kotak Mahindra Mutual Fund monthly portfolios

Value of change = the difference in shares × this month's price in the AMC's file. Value now = the whole holding's market value in that file (an exit: last month's).

How to read

Report a wrong number

Full portfolio, Oct 2026 (34 stocks)

Every listed stock in the month's file, largest first.

largest first, by value
Company Sector
SUNPHARMASun Pharmaceutical Industries Limited Healthcare6.50 lakh₹116 cr13.42%
DIVISLABDivi's Laboratories Limited Healthcare90,000₹88.0 cr10.23%
ACUTAASAcutaas Chemicals Limited Healthcare1.05 lakh₹42.0 cr4.88%
MOLBIOMolbio Diagnostics Limited Healthcare3.20 lakh₹40.8 cr4.74%
TORNTPHARMTorrent Pharmaceuticals Limited Healthcare80,000₹36.9 cr4.29%
LAURUSLABSLaurus Labs Limited Healthcare1.50 lakh₹36.1 cr4.19%
MAXHEALTHMax Healthcare Institute Limited Healthcare3.50 lakh₹30.1 cr3.50%
APOLLOHOSPApollo Hospitals Enterprise Limited Healthcare33,000₹27.9 cr3.24%
GLANDGland Pharma Limited Healthcare90,000₹27.9 cr3.24%
CIPLACipla Limited Healthcare2.00 lakh₹27.6 cr3.20%
SAILIFESai Life Sciences Limited Healthcare1.60 lakh₹24.9 cr2.90%
YATHARTHYatharth Hospital & Trauma Care Serv Ltd Healthcare2.49 lakh₹23.1 cr2.68%
MANKINDMankind Pharma Limited Healthcare90,000₹22.4 cr2.61%
FORTISFortis Healthcare Limited Healthcare2.80 lakh₹21.5 cr2.50%
PRASOLCHEMPRASOL CHEMICALS LTD Chemicals2.65 lakh₹21.3 cr2.48%
KIMSKrishna Institute Of Medical Sciences Limited Healthcare3.00 lakh₹21.1 cr2.45%
PARKHOSPSPark Medi World Ltd. Healthcare9.50 lakh₹20.9 cr2.42%
MARKSANSMarksans Pharma Limited Healthcare6.25 lakh₹19.1 cr2.22%
ANTHEMAnthem Biosciences Limited Healthcare2.25 lakh₹18.6 cr2.17%
PARASHLTHParas Healthcare Limited Healthcare2.30 lakh₹17.0 cr1.98%
RUBICONRubicon Research Limited Healthcare1.00 lakh₹16.1 cr1.87%
AJANTPHARMAjanta Pharma Limited Healthcare45,000₹15.8 cr1.83%
ZYDUSLIFEZydus Lifesciences Limited Healthcare1.25 lakh₹15.6 cr1.81%
AUROPHARMAAurobindo Pharma Limited Healthcare85,000₹14.3 cr1.66%
EMCUREEmcure Pharmaceuticals Limited Healthcare75,000₹14.0 cr1.63%
VIYASHViyash Scientific Limited Healthcare6.00 lakh₹13.1 cr1.52%
CORONACorona Remedies Limited Healthcare60,000₹12.9 cr1.50%
METROPOLISMetropolis Healthcare Limited Healthcare2.00 lakh₹10.9 cr1.27%
ORCHPHARMAOrchid Pharma Limited Healthcare1.30 lakh₹10.9 cr1.26%
INNOVACAPInnova Captab Limited Healthcare1.00 lakh₹10.3 cr1.19%
JUBLINGREAJubilant Ingrevia Limited Chemicals1.70 lakh₹9.5 cr1.10%
JUBLPHARMAJubilant Pharmova Limited Healthcare1.00 lakh₹9.3 cr1.08%
LALPATHLABDr. Lal Path Labs Limited Healthcare44,000₹8.4 cr0.97%
LUPINLupin Limited Healthcare40,000₹8.0 cr0.93%
Show all 34 stocksShow the first 15

Equity rows as disclosed, Oct 2026. Source: Kotak Mahindra Mutual Fund monthly portfolio. Report a wrong number

Large, mid and small caps, % of net assets, last 12 months

AMFI list in force each month
MonthLargeMidSmallNot in AMFI's listAMFI list
Oct 202634.4%21.2%34.2%9.2%Jun 2026
Sep 202633.4%19.6%38.3%7.3%Jun 2026
Aug 202634.9%20.9%39.4%4.5%Jun 2026
Jul 202636.3%23.5%39.0%0.0%Jun 2026
Jun 202631.9%21.4%45.7%0.0%Dec 2025
May 202632.3%22.0%44.5%0.0%Dec 2025
Apr 202633.6%21.4%44.0%0.0%Dec 2025
Mar 202635.0%21.9%42.4%0.0%Dec 2025
Feb 202635.0%22.7%41.0%0.0%Dec 2025
Jan 202634.7%22.9%40.7%0.0%Dec 2025
Dec 202544.0%13.8%30.3%8.1%Jun 2025
Nov 202547.1%13.7%34.7%3.6%Jun 2025
Sources: Kotak Mahindra Mutual Fund monthly portfolios; AMFI. How to read

Equity holdings' % of net assets each month, by AMFI's cap list in force that month.

Portfolio turnover, from holdings

equity only · month-end snapshots
Turnover, 12 months32.6%Oct 2025 to Oct 2026 · bought ₹463 cr, sold ₹188 cr
MonthBoughtSoldTurnover
Oct 2026₹60.0 cr₹15.5 cr1.9%
Sep 2026₹67.7 cr₹1.2 cr0.2%
Aug 2026₹78.6 cr₹7.8 cr1.1%
Jul 2026₹75.3 cr₹89.3 cr11.2%
Jun 2026₹79.3 cr₹0.00 cr0.0%
May 2026₹34.2 cr₹3.3 cr0.6%
Apr 2026₹30.7 cr₹12.1 cr2.6%
Mar 2026₹0.00 cr₹19.7 cr0.0%
Feb 2026₹0.00 cr₹0.00 cr0.0%
Jan 2026₹16.8 cr₹7.2 cr1.6%
Dec 2025₹20.0 cr₹32.0 cr4.3%
Nov 2025₹0.00 cr₹0.00 cr0.0%
Source: Kotak Mahindra Mutual Fund monthly portfolios. How to read

The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.

Returns next to the benchmark

What the plan's NAV did over each period, as AMFI publishes it.

as of 19 Nov 2026 · as published by AMFI
PeriodDirect planRegular planBenchmark, as published by AMFI NIFTY Healthcare TRI
1 year+33.09 %+31.01 %+16.99 %
Since launch+23.69 %+21.70 %+20.58 %

Past performance may not be sustained in future.

Source: AMFI fund performance

As AMFI's fund performance report prints them for "Kotak Healthcare Fund"; this site computes no benchmark figure of its own.

How to read

How it is computed: NAV to NAV

Kotak Healthcare Fund - Direct Plan - Growth Option: these run to the newest NAV stored (20 Nov 2026) and are computed here from AMFI's NAV files; AMFI's figures above run to 19 Nov 2026, so the two differ by the days in between.

PeriodReturnFromTo
1 year+33.18 % in total 20 Nov 2025 · NAV ₹14.067020 Nov 2026 · NAV ₹18.7350
Since first NAV+23.76 % a year, compounded 18 Dec 2023 · NAV ₹10.040020 Nov 2026 · NAV ₹18.7350

Source: AMFI NAV files (plan code 152214). How to read Report a wrong number

IDCW (dividend) history

0 declarations · as of 3 Nov 2026 · Source: AMFI
AMFI lists no IDCW declared by this scheme.
Source: AMFI scheme dividends. How to read

IDCW (formerly "dividend") declared per unit of each IDCW plan, as AMFI lists it.

Rolling returns, Kotak Healthcare Fund - Direct Plan - Growth Option

weekly NAVs · Source: AMFI
WindowLowestMedianHighestWindows above zero
1 year in total −6.39 % 3 Jan 2025 to 9 Jan 2026+14.71 % 5 Jul 2024 to 11 Jul 2025+42.74 % 22 Dec 2023 to 27 Dec 2024 89 % of 100 windows ending 27 Dec 2024 to 20 Nov 2026

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

Every 1-, 3- and 5-year window ending on a week's last NAV, lowest, middle and highest.

Volatility, a year

Standard deviation of weekly NAV changes × √52. 22 Dec 2023 to 20 Nov 2026, 152 weekly changes.

Source: AMFI

15.74 %152 weeks to 20 Nov 2026
Largest fall from a high

High 3 Jan 2025, low 28 Feb 2025; back at the high 30 Apr 2026.

Weekly NAVs since 22 Dec 2023. Measured on each week's last NAV, so a fall within a week can be deeper than shown.

Source: AMFI

−17.60 %low 28 Feb 2025

Past performance may not be sustained in future.

Next to its category: Sectoral or thematic

weekly NAVs · Source: AMFI
Rolling windowLower quarterUpper quarterAbove 6 %Above 9 %Above 12 %Above the category average
1 year+3.1 %+21.1 % 71.0 %65.0 %57.0 % 79.0 % of 100 windows
How this is counted

Same windows as the rolling returns above. A quarter of the windows returned less than the lower quarter, and a quarter more than the upper. "Above" columns give the share of windows. The category average is the average for windows ending the same week.

Market phases

PhaseDatesThis schemeCategory average
Foreign selling, 2024–2527 Sep 2024 to 28 Feb 2025 in total−15.2 %−19.1 % 148 schemes
Since March 202528 Feb 2025 to 20 Nov 2026 a year, compounded+29.1 %+15.6 % 165 schemes

The phases are the site's own split of the market since 2015, measured from month end to month end.

From each quarter end to the newest NAV

FromDatesThis schemeCategory average
From Jun 202625 Jun 2026 to 20 Nov 2026 in total+14.6 %+4.6 % 195 schemes
From Mar 202627 Mar 2026 to 20 Nov 2026 in total+35.1 %+18.0 % 195 schemes
From Dec 202526 Dec 2025 to 20 Nov 2026 in total+36.6 %+6.8 % 188 schemes
From Sep 202526 Sep 2025 to 20 Nov 2026 a year, compounded+32.5 %+8.9 % 182 schemes
From Jun 202527 Jun 2025 to 20 Nov 2026 a year, compounded+24.8 %+6.0 % 173 schemes
From Mar 202528 Mar 2025 to 20 Nov 2026 a year, compounded+24.6 %+11.8 % 169 schemes
From Dec 202427 Dec 2024 to 20 Nov 2026 a year, compounded+15.0 %+5.8 % 159 schemes
From Sep 202427 Sep 2024 to 20 Nov 2026 a year, compounded+13.7 %+1.6 % 148 schemes
From Jun 202428 Jun 2024 to 20 Nov 2026 a year, compounded+21.8 %+5.4 % 139 schemes
From Mar 202428 Mar 2024 to 20 Nov 2026 a year, compounded+20.7 %+9.9 % 133 schemes
From Dec 202329 Dec 2023 to 20 Nov 2026 a year, compounded+23.1 %+11.5 % 127 schemes
Spread of falling weeks, a year

Root mean square of the weekly falls × √52 (rising weeks count as zero).

9.8 %22 Dec 2023 to 20 Nov 2026
Up capture

Its average change in the 89 weeks the category average rose, as a share of the category's.

105.9 %89 rising weeks
Down capture

The same for the 63 weeks the category average fell.

77.7 %63 falling weeks

Past performance may not be sustained in future.

Source: AMFI NAV files.

Category average = the plain average for the other schemes in the same AMFI category with the same figure (direct growth plans, each week's last NAV). It is not an index, and the scheme's place among them is not shown. Peers are today's schemes in today's category, so a scheme that has closed is not in the average, and SEBI re-sorted the categories in 2018.

52-week high NAV

Highest and lowest of 248 daily NAVs, 20 Nov 2025 to 20 Nov 2026, Kotak Healthcare Fund - Direct Plan - Growth Option.

Source: AMFI

₹18.847013 Nov 2026
52-week low NAV₹13.043029 Jan 2026

Calendar-year returns, Kotak Healthcare Fund - Direct Plan - Growth Option

NAV to NAV · Source: AMFI
YearReturnFromTo
2025−5.83 % 31 Dec 2024 · NAV ₹14.553031 Dec 2025 · NAV ₹13.7050
2024+41.86 % 29 Dec 2023 · NAV ₹10.259031 Dec 2024 · NAV ₹14.5530

Past performance may not be sustained in future.

Change in the plan's NAV over each calendar year, last NAV to last NAV. Source: AMFI NAV files. How to read

Monthly SIP of ₹10,000, Kotak Healthcare Fund - Direct Plan - Growth Option

XIRR · Source: AMFI
PeriodInstalmentsPaid inValueXIRR, a year
1 year 1 Dec 2025 to 2 Nov 202612 ₹1,20,000₹1,46,991 20 Nov 2026 · NAV ₹18.7350+47.04 %

Past performance may not be sustained in future.

Source: AMFI NAV files. How to read

₹10,000 on the first NAV of each month, valued at the newest NAV; no stamp duty, exit load or tax taken off.

Embed this card

Card for this scheme: facts with source and date

Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.

Portfolios most like this one, Oct 2026

same category, other fund houses
Most alike and most unique funds →

Overlap is the sum, over stocks both hold, of the smaller of the two weights. A measured likeness, not a suggestion to switch.

From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.

Questions about Kotak Healthcare Fund

from the figures on this page

What are the top holdings of Kotak Healthcare Fund?

At Oct 2026 end, Kotak Healthcare Fund held 34 stocks (99.0% of the fund in equity). Largest: Sun Pharmaceutical Industries 13.42%, Divi's Laboratories 10.23%, Acutaas Chemicals 4.88%, Molbio Diagnostics 4.74%, Torrent Pharmaceuticals 4.29%; the top 10 make up 54.9%. Funds holding Sun Pharmaceutical Industries · Funds holding Divi's Laboratories · Funds holding Acutaas Chemicals

What portfolio changes did Kotak Healthcare Fund make in Oct 2026?

Compared with Sep 2026, by share count: 1 new, 9 added, 0 trimmed, 2 exited. Largest by value: Paras Healthcare (new), Sun Pharmaceutical Industries (added), Divi's Laboratories (added), Laurus Labs (added).

Who manages Kotak Healthcare Fund?

AMFI's scheme summary document names Dhananjay Tikariha, Abhishek Bisen for Kotak Healthcare Fund (Kotak Mahindra Mutual Fund). Dhananjay Tikariha, fund manager portfolio · Abhishek Bisen, fund manager portfolio

All schemes of Kotak Mahindra Mutual Fund →

Mutual fund investments are subject to market risks; read all scheme related documents carefully.